Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]-2-furyl}-N-methylbenzenesulfonamide is a synthetic small molecule containing a thiazolidinone core linked to a furan ring and an N-methylbenzenesulfonamide group. Its molecular formula is C15H13N3O4S2[9]. The compound is structurally related to other thiazolidinone derivatives that have been studied for diverse biological activities, including antimicrobial and anticancer properties. However, there are no approved indications or clinical trial data available for this specific compound. Its mechanism of action and pharmacological targets remain uncharacterized in the public domain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]-2-furyl}-N-methylbenzenesulfonamide.